Cambridge Investment Research Advisors’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $637K | Sell |
12,239
-315
| -3% | -$16.4K | ﹤0.01% | 2324 |
|
2025
Q1 | $535K | Sell |
12,554
-4,043
| -24% | -$172K | ﹤0.01% | 2374 |
|
2024
Q4 | $507K | Buy |
16,597
+6,769
| +69% | +$207K | ﹤0.01% | 2419 |
|
2024
Q3 | $225K | Buy |
9,828
+41
| +0.4% | +$939 | ﹤0.01% | 3051 |
|
2024
Q2 | $283K | Sell |
9,787
-16,692
| -63% | -$483K | ﹤0.01% | 2746 |
|
2024
Q1 | $546K | Buy |
26,479
+1,641
| +7% | +$33.8K | ﹤0.01% | 2210 |
|
2023
Q4 | $672K | Sell |
24,838
-846
| -3% | -$22.9K | ﹤0.01% | 1950 |
|
2023
Q3 | $761K | Buy |
25,684
+11,498
| +81% | +$341K | ﹤0.01% | 1751 |
|
2023
Q2 | $508K | Sell |
14,186
-393
| -3% | -$14.1K | ﹤0.01% | 2125 |
|
2023
Q1 | $342K | Buy |
14,579
+6,464
| +80% | +$152K | ﹤0.01% | 2370 |
|
2022
Q4 | $221K | Buy |
8,115
+2,074
| +34% | +$56.5K | ﹤0.01% | 2670 |
|
2022
Q3 | $325K | Buy |
+6,041
| New | +$325K | ﹤0.01% | 2298 |
|
2022
Q1 | – | Sell |
-2,860
| Closed | -$286K | – | 3218 |
|
2021
Q4 | $286K | Sell |
2,860
-2,014
| -41% | -$201K | ﹤0.01% | 2566 |
|
2021
Q3 | $609K | Buy |
4,874
+136
| +3% | +$17K | ﹤0.01% | 1897 |
|
2021
Q2 | $588K | Sell |
4,738
-3,574
| -43% | -$444K | ﹤0.01% | 1927 |
|
2021
Q1 | $1.27M | Sell |
8,312
-7,741
| -48% | -$1.18M | 0.01% | 1271 |
|
2020
Q4 | $2.07M | Buy |
16,053
+7,639
| +91% | +$985K | 0.01% | 907 |
|
2020
Q3 | $941K | Buy |
8,414
+2,720
| +48% | +$304K | 0.01% | 1224 |
|
2020
Q2 | $462K | Buy |
5,694
+725
| +15% | +$58.8K | ﹤0.01% | 1600 |
|
2020
Q1 | $346K | Sell |
4,969
-58
| -1% | -$4.04K | ﹤0.01% | 1592 |
|
2019
Q4 | $393K | Buy |
5,027
+806
| +19% | +$63K | ﹤0.01% | 1738 |
|
2019
Q3 | $269K | Buy |
+4,221
| New | +$269K | ﹤0.01% | 1907 |
|
2019
Q2 | – | Sell |
-3,070
| Closed | -$235K | – | 2258 |
|
2019
Q1 | $235K | Buy |
+3,070
| New | +$235K | ﹤0.01% | 1964 |
|